Patrick D Spangler insider trades: OptimizeRx (OPRX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Patrick reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | OPRX | ↓ Sell | 11,120 | $17.49 | $194K | Direct | Sep 11, 2025 (14d) |
| Nov 11, 2021 | OPRX | ↓ Sell | 6,252 | $84.38 | $528K | Direct | Nov 15, 2021 (4d) |
| Jun 27, 2018 | OPRX | ↑ Buy | 95 | $9.95 | $945 | Direct | Jun 28, 2018 (1d) |
| Nov 17, 2008 | EVVV | ↓ Sell10b5-1 | 2,322 | $5.16 | $12K | Direct | Nov 18, 2008 (1d) |
| Nov 16, 2007 | EVVV | ↓ Sell10b5-1 | 1,645 | $15.05 | $25K | Direct | Nov 19, 2007 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other OPRX insiders
Open-market trades in the last 12 months
About Patrick D Spangler's insider trades
Patrick D Spangler is a director at OptimizeRx (OPRX). Since Nov 16, 2007, Patrick has reported 1 open-market purchase worth $945 and 4 sales worth $759K on SEC Form 4. There have been no open-market trades in the last 12 months.
2 sales (5% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.
Their filings also include grants and awards (27 filings), option exercises (5 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every OPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.